Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
D. Boral Capital Cuts Carisma Therapeutics (NASDAQ:CARM) Price Target to $12.00
Carisma Therapeutics (NASDAQ:CARM – Get Free Report) had its price target cut by analysts at D. Boral Capital from $24.00...
SL Green Realty (NYSE:SLG) Updates FY 2025 Earnings Guidance
SL Green Realty (NYSE:SLG – Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided EPS...
SGL Investment Advisors Inc. Takes Position in Johnson & Johnson (NYSE:JNJ)
SGL Investment Advisors Inc. acquired a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) in the 3rd quarter,...
Eli Lilly and Company (NYSE:LLY) Shares Bought by Guardian Wealth Management Inc.
Guardian Wealth Management Inc. raised its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.8%...
Gordian Capital Singapore Pte Ltd Reduces Stake in Alphabet Inc. (NASDAQ:GOOG)
Gordian Capital Singapore Pte Ltd lowered its position in shares of Alphabet Inc. (NASDAQ:GOOG – Free Report) by 19.9% in...
JPMorgan Chase & Co. (NYSE:JPM) Stock Position Boosted by Raelipskie Partnership
Raelipskie Partnership lifted its holdings in JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 3.0% during the 3rd quarter,...